🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: F511 cream may prevent or reduce palmar-plantar erythrodysesthes...
Status
Completed
Location
Kantonsspital Aarau
Start Date
2009-09
Trial ID
NCT00992706
Treatments Being Tested
This is a multicenter, randomized, double-blind, phase II clinical study to...
Status
Recruiting
Location
Cancer Hospital Chinese Academy of Medical Science and Peking Union Medical College
Start Date
2022-09-06
Trial ID
NCT06014528
Treatments Being Tested
This trial is to evaluate if dexrazoxane is safer and more effective than l...
Status
Recruiting
Location
Beth Israel Deaconess Medical Center
Start Date
2026-08-31
Trial ID
NCT07654426
The purpose of this study is to compare progression-free survival (PFS) (ba...
Status
Terminated
Location
Multiple Locations
Start Date
2011-04-22
Trial ID
NCT01170650
Treatments Being Tested
This is a multicenter, multinational, randomized, double-blind, 2-arm, para...
Status
Terminated
Location
University of Alabama at Birmingham Comprehensive Cancer Center
Start Date
2016-06
Trial ID
NCT02641639
Treatments Being Tested
The purpose of the trial is to compare the effectiveness and safety of 2 tr...
Status
Active Not Recruiting
Location
Mayo Clinic
Start Date
2022-06-28
Trial ID
NCT05281328
MORAb-003-011 is a global, multicenter, double-blind, randomized placebo-co...
Status
Completed
Location
Multiple Locations
Start Date
2015-03-19
Trial ID
NCT02289950
Treatments Being Tested
Atezolizumab in this study is expected to have a positive benefit-risk prof...
Status
Completed
Location
Grand Hôpital de Charleroi
Start Date
2018-11-21
Trial ID
NCT03598270
This is a Phase 1b/2 study of AVB-S6-500 in combination with pegylated lipo...
Status
Completed
Location
Arizona Oncology
Start Date
2018-12-06
Trial ID
NCT03639246
Treatments Being Tested
To determine if AMG 386 plus pegylated liposomal doxorubicin (PLD) is super...
Status
Terminated
Location
Research Site
Start Date
2011-04-18
Trial ID
NCT01281254
Treatments Being Tested